Cardiff Oncology, Inc.

CRDF·NASDAQ·$1.94Share Price as of 11/2·$133MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/14/26 10-KFY 202502/24/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2507/29/25

Disclosures

8-KCurrent report10/27/26 8-KCurrent report10/22/26 8-KCurrent report09/14/26 8-KCurrent report08/11/26 8-KCurrent report07/16/26

Prospectuses and Registrations

S-8Registration of securities for employees07/21/26 424B5Prospectus supplement07/16/26 S-8Registration of securities for employees08/28/25 S-3/AShelf registration (amended)05/08/25 S-3Shelf registration02/27/25

Proxies

DEF 14ADefinitive proxy08/26/26 DEFA14AAdditional proxy materials08/26/26 PRE 14APreliminary proxy08/14/26 DEF 14ADefinitive proxy04/23/26 DEFA14AAdditional proxy materials04/23/26

Ownership

Form 3Initial insider ownership10/27/26 Form 4Insider transaction07/16/26 Form 4Insider transaction07/16/26 Form 4Insider transaction06/22/26 Form 4Insider transaction06/22/26

Other

ARSAnnual report to shareholders04/23/26 EFFECTRequest for effectiveness05/13/25 CORRESPCorrespondence with the SEC05/12/25 ARSAnnual report to shareholders04/29/25 UPLOADLetter from the SEC03/06/25